Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hantel

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2022
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for InterventionAndrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Journal of the National Cancer Institute|March 22, 2024
Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemiaAndrew Hantel, Andrew M Brunner, Jesse J Plascak, et al.
BMC Medicine|January 28, 2026
Ethical dilemmas in climate change and healthcare delivery: a cross-sectional survey of US patient perspectivesAndrew Hantel, Emily Senay, Fay J Hlubocky, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 13, 2026
Translation approaches to support systemic anti-cancer therapy consent for individuals with limited English proficiencyStephen P Hibbs, Rumman Nizam, Ubaid Tanzim, et al.
Leukemia|January 25, 2021
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Blood Advances|January 15, 2026
Stratifying Survival: The Role of Social Determinants of Health on AML Outcomes by ELN 2022 CriteriaShai Shimony, Yating Wang, Angel M Cronin, et al.
Journal of Oncology Practice|September 8, 2016
No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit HospitalizationsBobby Daly, Andrew Hantel, Kristen Wroblewski, et al.
Blood Advances|May 17, 2023
Association of social deprivation with survival in younger adult patients with AML: an Alliance studyMelanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Blood|October 16, 2025
Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical TrialsAndrew Hantel, Yating Wang, Angel Cronin, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2022
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for InterventionAndrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Journal of the National Cancer Institute|March 22, 2024
Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemiaAndrew Hantel, Andrew M Brunner, Jesse J Plascak, et al.
BMC Medicine|January 28, 2026
Ethical dilemmas in climate change and healthcare delivery: a cross-sectional survey of US patient perspectivesAndrew Hantel, Emily Senay, Fay J Hlubocky, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 13, 2026
Translation approaches to support systemic anti-cancer therapy consent for individuals with limited English proficiencyStephen P Hibbs, Rumman Nizam, Ubaid Tanzim, et al.
Leukemia|January 25, 2021
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Blood Advances|January 15, 2026
Stratifying Survival: The Role of Social Determinants of Health on AML Outcomes by ELN 2022 CriteriaShai Shimony, Yating Wang, Angel M Cronin, et al.
Journal of Oncology Practice|September 8, 2016
No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit HospitalizationsBobby Daly, Andrew Hantel, Kristen Wroblewski, et al.
Blood Advances|May 17, 2023
Association of social deprivation with survival in younger adult patients with AML: an Alliance studyMelanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Blood|October 16, 2025
Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical TrialsAndrew Hantel, Yating Wang, Angel Cronin, et al.
Pageof 7